Parathyroid Hormone - Administration & dosage
Research News and Information

Sunday, November 22, 2009

Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment.

29 Nov 2009 The osteo-anabolic effects of intermittent parathyroid hormone (PTH) treatment require insulin-like growth factor (IGF) signaling through the IGF-I receptor. A major downstream target of the IGF-I receptor (via Akt) is the mammalian target of ... Read more...

Short-term effects of parathyroid hormone on rat lumbar vertebrae.

30 Aug 2009 STUDY DESIGN: This study is an experimental study in the rat osteopenia model. OBJECTIVE: The aim of this study was to evaluate the short-term effects of daily application of parathyroid hormone (PTH) on bone quality and quantity using a new ... Read more...

Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone.

30 May 2009 The nucleocytoplasmic shuttling transcription factor Nmp4/CIZ (nuclear matrix protein 4/cas interacting zinc finger protein) is a ubiquitously expressed protein that regulates both cytoplasmic and nuclear activities. In the nucleus, Nmp4/CIZ ... Read more...

Latest indexed articles for 'Parathyroid Hormone - Administration & dosage'

These are the very latest articles for this heading:

• Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment. 29 Nov 2009
• Short-term effects of parathyroid hormone on rat lumbar vertebrae. 30 Aug 2009
• Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone. 30 May 2009
• A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level. 30 May 2009
• K+-dependent Na+/Ca2+ exchanger 3 is involved in renal active calcium transport and is differentially expressed in the mouse kidney. 25 May 2009
• [Combination therapy for osteoporosis] 29 Apr 2009
• Age-related efficacy of parathyroid hormone on osseointegration in the rat. 30 Mar 2009
• ...About osteoporosis. 30 Jan 2009
• Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. 13 Jan 2009
• Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. 2 Jan 2009
• [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis] 30 Dec 2008
• Parathyroid hormone treatment for osteoporosis. 29 Nov 2008
• Intermittent PTH administration: a novel therapy method for periodontitis-associated alveolar bone loss. 28 Nov 2008
• Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. 18 Nov 2008
• Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. 20 Oct 2008
• Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. 15 Oct 2008
• [PTH and mechanical stress] 30 Aug 2008
• Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide. 12 Aug 2008
• EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. 30 Jul 2008
• Exogenous PTH and endogenous 1,25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone. 30 Jul 2008

See a longer list of these articles.

Technical information about 'Parathyroid Hormone'

Definition: A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.

Registry Number: 0

Descriptor UI: D010281

Alternative terms: Parathyroid Hormone; Hormone, Parathyroid; PTH (1-84); Parathyroid Hormone (1-84); Parathormone; Parathyrin; Parathyroid Hormone Peptide (1-34); PTH(1-34); Parathyroid Hormone (1-34);

Related Mesh Headings: Hypoparathyroidism; Parathyroid Hormone-Related Protein;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D06.472.699.590; D12.644.548.587;

History Note: 2004(1963-1981); for PARATHYROID HORMONE PEPTIDE (1-34) use TERIPARATIDE 1997-2007

Technical Notes: /defic: consider also HYPOPARATHYROIDISM